In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.

As of close of business last night, Immunovant Inc’s stock clocked out at $16.4, up 0.18% from its previous closing price of $16.37. In other words, the price has increased by $0.18 from its previous closing price. On the day, 1.36 million shares were traded. IMVT stock price reached its highest trading level at $16.59 during the session, while it also had its lowest trading level at $16.29.

Ratios:

To gain a deeper understanding of IMVT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.32 and its Current Ratio is at 12.32. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jul 23 ’25 when Stout Jay S sold 2,805 shares for $18.15 per share. The transaction valued at 50,911 led to the insider holds 204,919 shares of the business.

Geffner Michael sold 2,385 shares of IMVT for $43,288 on Jul 23 ’25. The Chief Medical Officer now owns 221,825 shares after completing the transaction at $18.15 per share. On Jul 09 ’25, another insider, Geffner Michael, who serves as the Chief Medical Officer of the company, sold 1,160 shares for $17.24 each. As a result, the insider received 19,998 and left with 224,210 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IMVT now has a Market Capitalization of 2858798592 and an Enterprise Value of 2259884288.

Stock Price History:

The Beta on a monthly basis for IMVT is 0.46, which has changed by -0.4354561 over the last 52 weeks, in comparison to a change of 0.1725707 over the same period for the S&P500. Over the past 52 weeks, IMVT has reached a high of $34.18, while it has fallen to a 52-week low of $12.72. The 50-Day Moving Average of the stock is 0.39%, while the 200-Day Moving Average is calculated to be -13.14%.

Shares Statistics:

It appears that IMVT traded 1.35M shares on average per day over the past three months and 1654660 shares per day over the past ten days. A total of 171.07M shares are outstanding, with a floating share count of 70.59M. Insiders hold about 59.50% of the company’s shares, while institutions hold 55.30% stake in the company. Shares short for IMVT as of 1755216000 were 16067954 with a Short Ratio of 11.89, compared to 1752537600 on 20574064. Therefore, it implies a Short% of Shares Outstanding of 16067954 and a Short% of Float of 26.88.

Earnings Estimates

Currently, 12.0 analysts are dedicated to thoroughly evaluating and rating the performance of Immunovant Inc (IMVT) in the stock market.The consensus estimate for the next quarter is -$0.73, with high estimates of -$0.6 and low estimates of -$0.87.

Analysts are recommending an EPS of between -$2.33 and -$3.32 for the fiscal current year, implying an average EPS of -$2.88. EPS for the following year is -$2.99, with 9.0 analysts recommending between -$1.96 and -$3.98.